Cargando…
366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512916/ http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6 |
_version_ | 1782251832243912704 |
---|---|
author | Pomies, Valeria Ale, Iris |
author_facet | Pomies, Valeria Ale, Iris |
author_sort | Pomies, Valeria |
collection | PubMed |
description | BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammatory drugs, and corticosteroids. Certain body areas are particularly susceptible (ie, genital and perianal areas, ears, eyes, face and lower legs) Predisposing factors are: occlusion (skin folds, use of bandages), application in damaged skin (stasis dermatitis & leg ulcers, and other chronic dermatitis) and long-lasting use of multiple medicaments The aim of our study was to study the prevalence of ACD to topical medicaments in patients with suspected ACD attending the Unit of Allergy at the University Hospital in Montevideo. METHODS: 1175 consecutive patients; 781 F (63%) 394 M (37%) with suspected ACD were patch tested with the standard series and the topical medicament series, as well as other allergens according to the clinical situation. RESULTS: The most frequent allergens were: Neomycin (7.1%), Thiomersal (3.8%), Benzocaine (1.9%), Bacitracin (1.9%), Propolis (1.5%), Gentamycin (1.2%), Tixocortol (1.1%) and Budesonide 24 (0.8%). CONCLUSIONS: Contact allergy to topical medicaments is common in patients studied by a suspected ACD in Uruguay. In these cases the topical medicaments that the patient is using should be included when patch testing. |
format | Online Article Text |
id | pubmed-3512916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | World Allergy Organization Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-35129162012-12-21 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay Pomies, Valeria Ale, Iris World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammatory drugs, and corticosteroids. Certain body areas are particularly susceptible (ie, genital and perianal areas, ears, eyes, face and lower legs) Predisposing factors are: occlusion (skin folds, use of bandages), application in damaged skin (stasis dermatitis & leg ulcers, and other chronic dermatitis) and long-lasting use of multiple medicaments The aim of our study was to study the prevalence of ACD to topical medicaments in patients with suspected ACD attending the Unit of Allergy at the University Hospital in Montevideo. METHODS: 1175 consecutive patients; 781 F (63%) 394 M (37%) with suspected ACD were patch tested with the standard series and the topical medicament series, as well as other allergens according to the clinical situation. RESULTS: The most frequent allergens were: Neomycin (7.1%), Thiomersal (3.8%), Benzocaine (1.9%), Bacitracin (1.9%), Propolis (1.5%), Gentamycin (1.2%), Tixocortol (1.1%) and Budesonide 24 (0.8%). CONCLUSIONS: Contact allergy to topical medicaments is common in patients studied by a suspected ACD in Uruguay. In these cases the topical medicaments that the patient is using should be included when patch testing. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512916/ http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6 Text en Copyright © 2012 by World Allergy Organization |
spellingShingle | Abstracts of the XXII World Allergy Congress Pomies, Valeria Ale, Iris 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title | 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title_full | 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title_fullStr | 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title_full_unstemmed | 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title_short | 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay |
title_sort | 366 contact allergy to medicaments in consecutively patch-tested patients in uruguay |
topic | Abstracts of the XXII World Allergy Congress |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512916/ http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6 |
work_keys_str_mv | AT pomiesvaleria 366contactallergytomedicamentsinconsecutivelypatchtestedpatientsinuruguay AT aleiris 366contactallergytomedicamentsinconsecutivelypatchtestedpatientsinuruguay |